(Q41259403)

28 September 2017

title

Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A405166

22 April 2023

1 reference

R. B. Faanes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A405166

22 April 2023

P. Dillon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A405166

22 April 2023

Y. S. Choi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A405166

22 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=405166

22 April 2023

publication date

1 March 1977

1 reference

full work available at URL

28 September 2017

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/405166/?tool=EBI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A405166

Clinical and Experimental Immunology

22 April 2023

published in

1 reference

28 September 2017

volume

27

1 reference

28 September 2017

issue

3

1 reference

28 September 2017

page(s)

502-506

1 reference

Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro

28 September 2017

cites work

1 reference

12 December 2020

Levamisole inactive in treatment of four animal tumours

1 reference

12 December 2020

Levamisole Inhibits and Cures a Solid Malignant Tumour and its Pulmonary Metastases in Mice

1 reference

12 December 2020

Cell-mediated cytotoxicity, allograft rejection, and tumor immunity

1 reference

12 December 2020

Characterization of the immunostimulants levamisole and tetramisole

1 reference

12 December 2020

Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection

1 reference

12 December 2020

[Immunostimulating action of phenylimidothiazole derivatives on spleen antibody-producing cells]

1 reference

12 December 2020

Modulation of immune reactivity by phenylimidothiazole salts in mice immunized by sheep red blood cells

1 reference

12 December 2020

Restoration of cell-mediated immunity to animals blocked by a humoral response

1 reference

12 December 2020

Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant

1 reference

12 December 2020

Escape from isoantiserum inhibition of lymphocyte-mediated cytotoxicity

1 reference

12 December 2020

Rejection of ascites tumor allografts. I. Isolation, characterization, and in vitro reactivity of peritoneal lymphoid effector cells from BALB-c mice immune to EL4 leukosis

1 reference

12 December 2020

Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity

1 reference

12 December 2020

Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: studies on cell-mediated immunity and humoral antibody response

1 reference

12 December 2020

Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum

1 reference

12 December 2020

Identifiers

PMC publication ID

1540944

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=405166

22 April 2023

1 reference